Epkinly monotherapy significantly improved progression-free survival in relapsed/refractory DLBCL patients, reducing cancer ...

Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-9 study of TECVAYLI® ...

Initiation of phase 1 portion of the trial planned in 2H 2026-Phase 2 portion of the trial will initiate development of the elraglusib tablet in ...

Patients were randomly assigned on a 1:1 basis to receive teclistamab as monotherapy or physician’s choice of ...

Researchers noted that despite the promising findings, more novel treatments are needed to overcome the disease’s resistance. Patients with penta-relapsed refractory multiple myeloma (RRMM) exhibited ...

Company Announcement Based on the topline results from the EPCORE® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss ...

SAN FRANCISCO — A focused form of radiation akin to that used to destroy solid tumors may be effective at controlling high-risk ventricular arrhythmias in patients who failed to respond to an initial ...

A new clinical practice update outlines a stepwise approach to diagnosing and managing refractory constipation before ...

A new update from the American Gastroenterological Association (AGA) is calling for greater caution before surgery is considered for patients with refractory constipation, a severe, chronic form of ...

Chronic constipation affects 8–12% of Americans. While most patients improve with conventional treatments, a small but challenging subset remains refractory. These patients often undergo extensive ...